Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial
三氟尿苷-替吡嘧啶治疗既往接受过治疗的雌激素受体阳性、HER2阴性转移性乳腺癌患者(BOOG 2019-01 TIBET试验):一项单臂、多中心、II期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.103065
Guchelaar, Niels A D; Mathijssen, Ron H J; de Boer, Maaike; van Bekkum, Marlies L; Heijns, Joan B; Vriens, Birgit E P J; van Rosmalen, Mandy M; Kessels, Lonneke W; Hamming, Lisanne; Beelen, Karin J; Nieboer, Peter; van den Berg, Susan M; Hoop, Esther Oomen-de; Bijlsma, Rhodé M; Bos, Monique E M M